Introduction Zeria Pharmaceutical is a company that specializes in manufacturing various products including veterinary medications, agricultural and industrial chemicals, reagents, cosmetics, health foods, alcoholic and non-alcoholic beverages, food additives, livestock feed, hygiene products, medical devices, and other related items. |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 13 |
Antibody | 1 |
Chemical drugs | 1 |
Biological products | 1 |
Target |
Mechanism Potassium modulators |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date21 Oct 2015 |
Mechanism A1R antagonists [+3] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. JP |
First Approval Date25 Mar 2013 |
Target |
Mechanism Bacterial RNAP inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date27 May 2011 |
Start Date03 Aug 2021 |
Sponsor / Collaborator |
Start Date10 May 2021 |
Sponsor / Collaborator |
Start Date22 Feb 2021 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Zaltoprofen ( COX ) | Inflammation More | Approved |
Disodium Phosphate/Monosodium Phosphate | Hypophosphatemia More | Approved |
Polaprezinc ( NF-κB ) | Stomach Ulcer More | Approved |
Ferric Carboxymaltose | Anemia, Iron-Deficiency More | Approved |
Mesalamine ( PP2A ) | Colitis, Ulcerative More | Approved |